A McGill-led team of researchers have made an important discovery shedding light on the genetic basis of a rare skeletal disorder.
Pfizer plans another $500M in cost cuts, expects $3.1B in revenue from Seagen in 2024
Pfizer’s not-so-good year continues. The New York pharma giant’s shares $PFE slid 7% before Wednesday’s opening bell after Pfizer said it plans to cut another